Chris Delany is currently the Senior Director of CMC Analytical Chemistry at Eli Lilly and Company. They hold a Bachelor of Science degree in Biological Science from Colorado State University, with an emphasis on Cellular, Molecular, and Genetic Biology. With continuous involvement in pharmaceutical sciences since 1993, they have developed extensive expertise in analytical chemistry, method development, and regulatory compliance. Prior roles include Associate Director of Pharmaceutical Development at Nivalis Therapeutics and various positions in other pharmaceutical organizations, where they contributed to drug product development and quality control efforts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices